Cyclosporine A-induced changes to erythrocyte redox balance is time course-dependent

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 3, 2005, Pages 135-140

  Lexis, Louise A ^a,c   Richards, Ross S ^a   Fassett, Robert G ^b,c   Coombes, Jeff S ^b,c  

^a CHARLES STURT UNIVERSITY   (Australia)

^b LAUNCESTON GENERAL HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; CREATININE; CYCLOSPORIN A; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; MALONALDEHYDE; METHEMOGLOBIN; PEROXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CATALASE; CYCLOSPORINE; ERYTHROCYTES; GLUTATHIONE PEROXIDASE; HEMOGLOBINS; IMMUNOSUPPRESSIVE AGENTS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METHEMOGLOBIN; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

ANIMALIA;

EID: 24744460712     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_973120.x     Document Type: Article

References (44)

1. Andersen, H. R., J. B. Nielsen, F. Nielsen & P. Grandjean: Antioxidative enzyme activities in human erythrocytes. Clin. Chem. 1997, 43, 562-568.
2. Beutler, E., O. Duron & B. M. Kelly: Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963, 61, 882-888.
3. Bonithon-Kopp, C., C. Coudray, C. Berr, P. J. Touboul, J. M. Feve, A. Favier & P. Ducimetiere: Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Arteriel. Amer. J. Clin. Nutr. 1997, 65, 121-127.
4. Chance, B., H. Sies & A. Boveris: Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 1979, 59, 527-605.
5. Cristol, J. P., M. F. Maggi, C. Vela, B. Descomps & G. Mourad: Lipid metabolism and oxidative stress in renal transplantation: implications for chronic rejection. Transplant. Proc. 1996, 28, 2820-2821.
6. Cristol, J. P., C. Vela, M. F. Maggi, B. Descomps & G. Mourad: Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 1998, 65, 1322-1328.
7. Durak, I., H. I. Karabacak, S. Buyukkocak, M. Y. Cimen, M. Kacmaz, E. Omeroglu & H. S. Ozturk: Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 1998, 78, 207-211.
8. Duruibe, V A., A. Okonmah & G. T. Blyden: Effect of ciclosporin on rat liver and kidney glutathione content. Pharmacology 1989, 39, 205-212.
9. Evelyn, K. & H. Malloy: Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J. Biol. Chem. 1938, 126, 655-662.
10. Fletcher, L. A., R. G. Fassett, R. S. Richards & J. S. Coombes: Cyclosporine A induced changes to plasma and erythrocyte antioxidant defences. Redox Rep. 2005, 10, 2-8.
11. Halliwell, B. & J. M. Gutteridge: Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 1986, 246, 501-514.
12. Hatam, L. J. & H. J. Kayden: A high-performance liquid chromatocgraphic method for the determination of tocopherol in plasma and cellular elements of the blood. J. Lipid Res. 1979, 20, 639-645.
13. Hatherill, J. R., G. O. Till & P. A. Ward: Mechanisms of oxidant-induced changes in erythrocytes. Agents Actions 1991, 32, 351-358.
14. Holvoet, P., J. Van Cleemput, D. Collen & J. Vanhaecke: Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 698-702.
15. Hussein, O., M. Rosenblat, G. Refael & M. Aviram: Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Transplantation 1997, 63, 679-685.
16. Ibarra, A., G. Guizar-Sahagun, D. Correa, R. Kretschmer, I. Grijalva, F. J. Flores-Murrieta, G. Castaneda-Hernandez, A. Odor, R. M. Lopez, R. Franco-Bourland, A. L. Espitia, H. Salgado-Ceballos & I. Madrazo: Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury. J. Neurotrauma 1996, 13, 267-272.
17. Kendrick, E.: Cardiovascular disease and the renal transplant recipient. Amer. J. Kidney Dis. 2001, 38, S36-43.
18. Lindholm, A.: Factors influencing the pharmacokinetics of cyclosporine in man. Ther. Drug Monit. 1991, 13, 465-477.
19. Lohr, G. W. & H. D. Waller: Glucose-6-phosphate dehydrogenase. In: Methods of enzymatic analysis. Ed.: H. U. Bergmeyer. Academic Press, New York, USA, 1974, pp. 636-643.
20. Madesh, M. & K. A. Balasubramanian: Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian J. Biochem. Biophys. 1998, 35, 184-188.
21. Massafra, C., D. Gioia, C. De Felice, M. Muscettola, M. Longini & G. Buonocore: Gender-related differences in erythrocyte glutathione peroxidase activity in healthy subjects. Clin. Endocrinol. 2002, 57, 663-667.
22. May, J. M., Z. Qu & C. E. Cobb: Extracellular reduction of the ascorbate free radical by human erythrocytes. Biochem. Biophys. Res. Commun. 2000, 267, 118-123.
23. Miller, N. J., C. Rice-Evans, M. J. Davies, V. Gopinathan & A. Milner: A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 1993, 84, 407-412.
24. Nath, K. A. & A. K. Salahudeen: Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J. Clin. Invest. 1990, 86, 1179-1192.
25. Nuttall, S. L., M. J. Kendall & U. Martin: Antioxidant therapy for the prevention of cardiovascular disease. Quart. J. Med. 1999, 92, 239-244.
26. Nyyssönen, K., M. T. Parviainen, R. Salonen, J. Tuomilehto & J. T. Salonen: Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from Eastern Finland. Brit. Med. J. 1997, 314, 634-638.
27. Oellerich, M. & V. W. Armstrong: Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy? Ther. Drug Monit. 2002, 24, 40-46.
28. O'Neill, J. O., D. O. Taylor & R. C. Starling: Immunosuppression for cardiac transplantation-the past, present and future. Transplant. Proc. 2004, 36, 309S-313S.
29. Parra Cid, T., J. R. Conejo Garcia, F. Carballo Alvarez & G. de Arriba: Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology 2003, 189, 99-111.
30. Pell, M. A., T. G. Rosano, K. L. Brayman, B. M. Freed, L. M. Shaw & N. Lempert: Predominance of native cyclosporine over metabolites in rat blood and tissue. Transplant. Proc. 1988, 20, 674-679.
31. Phair, P. G., H. R. Powell & D. A. McCredie: Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients. Transplant. Proc. 1994, 26, 3722-3726.
32. Santori, L., M. Rastelli, B. Arena & M. A. Morleo: Cyclosporine: update on pharmacology, analytical techniques and therapeutic monitoring. Boll. Chim. Farm. 1997, 136, 577-588.
33. Serino, F., J. Grevel, K. L. Napoli, B. D. Kahan & H. W. Strobel: Oxygen radical formation by the cytochrome P450 system as a cellular mechanism for cyclosporine toxicity. Transplant. Proc. 1994, 26, 2916-2917.
34. Sim, A. S., C. Salonikas, D. Naidoo & D. E. Wilcken: Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 785, 337-344.
35. Simic-Ogrizovic, S., T. Simic, Z. Reljic, S. Markovic, R. Blagojevic, D. Radivojevic, V. Lezaic, L. Djukanovic & J. Mimic-Oka: Markers of oxidative stress after renal transplantation. Transpl. Int. 1998, 11 Suppl 1, S125-129.
36. Slaughter, M. R. & P. J. O'Brien: Fully-automated spectrophoto-metric method for measurement of antioxidant activity of catalase. Clin. Biochem. 2000, 33, 525-534.
37. Taibi, G. & C. M. Nicotra: Development and validation of a fast and sensitive chromatographic assay for all-trans-retinol and tocopherols in human serum and plasma using liquid-liquid extraction. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2002, 780, 261-267.
38. Taniguchi, N.: Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer. Adv. Clin. Chem. 1992, 29, 1-59.
39. Taylor, J. E., N. Scott, A. Hill, A. Bridges, I. S. Henderson, W. K. Stewart & J. J. Belch: Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients. Transplantation 1993, 55, 500-504.
40. Wagner, O., E. Schreier, F. Heitz & G. Maurer: Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab. Dispos. 1987, 15, 377-383.
41. Wang, C. & A. K. Salahudeen: Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int. 1995, 47, 927-934.
42. Winterbourn, C. C.: Oxidative reactions of hemoglobin. Meth. Enzymol. 1990, 186, 265-272.
43. Wolf, A., C. F. Trendelenburg, C. Diez-Fernandez, P. Prieto, S. Houy, W. E. Trommer & A. Cordier: Cyclosporine A-induced oxidative stress in rat hepatocytes. J. Pharmacol. Exp. Therap. 1997, 280, 1328-1334.
44. Yu, B. P.: Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 1994, 74, 139-162.